Objective To conduct a systematic review and meta-analysis of the long-term impact of infant
vaccination on the prevalence of hepatitis B virus (HBV) infection at the population level …

Abstract Background Hepatitis B virus (HBV) infection was long considered an important
public health concern in Burkina Faso and still represents a major cause of liver cancer and …

Since 1982, safe and effective hepatitis B virus (HBV) vaccines have been commercially
available first derived from plasma of HBV infected persons and later from yeast cells using …

Sexually transmitted infections (STIs) pose a significant threat to individual and public
health. They disproportionately affect adolescents and young adults. In a cross-sectional …

Purpose This review article focuses on preventing vertical transmission of hepatitis B virus
(HBV) among pregnant women living in sub-Saharan Africa (SSA), where disease is …

Abstract Background Hepatitis B virus (HBV) infection is highly endemic in the Colombian
Amazon basin. In Colombia, the universal hepatitis B vaccination in that area has been …

Abstract Background In Australia's Northern Territory, the hepatitis B virus (HBV)
subgenotype A2 (subtype adw2) vaccine was introduced in 1988 for Indigenous infants …

There is an increasing global recognition of the need for high-level investment in the control
of cancer alongside other major noncommunicable diseases (NCDs). At the Seventieth …

The Hepatitis B is a viral infection caused by Hepatitis B virus (HBV) which is a double
stranded DNA virus, a member of the Hepadnavidae family of viruses. World Health …

Shimakawa, Y; Lemoine, M; Njai, HF; Bottomley, C; Ndow, G; Goldin, RD; Jatta, A; Jeng-Barry,
A; Wegmuller, R; Moore, SE; Baldeh, Page 1 Shimakawa, Y; Lemoine, M; Njai, HF; …